Epitel Secures $12.5 Million Series A Financing for Wearable, Wireless EEG Monitoring System
Epitel, Inc., a digital health company developing a wearable, wireless EEG monitoring platform for seizure detection, announced this week the closing of a $12.5 million Series A financing for initial pilot commercialization and further development of its proprietary platform.
Catalyst Health Ventures (CHV) and Genoa Ventures co-led the Series A financing along with participation from Dexcom and OSF Ventures.
In conjunction with this close, Vikram Chaudhery, Ph.D., of Genoa Ventures, and Joshua Phillips of CHV have been appointed to the Board of Directors.